PCN78 COST-EFFECTIVENESS ASSESSMENT OF ZOLEDRONIC ACID (ZOL) RELATIVE TO PLACEBO (PBO) IN THE TREATMENT OF LUNG CANCER PATIENTS WITH SKELETAL METASTASES IN FIVE EUROPEAN COUNTRIES
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74329-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)74329-1/fulltext
Title :
PCN78 COST-EFFECTIVENESS ASSESSMENT OF ZOLEDRONIC ACID (ZOL) RELATIVE TO PLACEBO (PBO) IN THE TREATMENT OF LUNG CANCER PATIENTS WITH SKELETAL METASTASES IN FIVE EUROPEAN COUNTRIES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74329-1&doi=10.1016/S1098-3015(10)74329-1
First page :
Section Title :
Open access? :
No
Section Order :
254